NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q4 2025

Type / Class
Equity / Common Stock, $0.01 par value
Symbol
NBY on NYSE
Shares outstanding
128,016,032
Price per share
$2.00
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6,077,642
Total reported value
$34,281,889
% of total 13F portfolios
0%
Share change
+5,862,074
Value change
+$33,149,447
Number of holders
25
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
R01 Fund LP 45% -0.22% $321,141,812 56,806,080 0% R01 Fund LP 16 Jan 2026
Framework Ventures IV L.P. 45% -0.22% $321,141,812 56,806,080 0% Framework Ventures IV L.P. 16 Jan 2026
Lazar David E. 5% -75% $36,028,320 +$27,556,589 6,388,000 +325% David E. Lazar 21 Oct 2025
POPLAR POINT CAPITAL MANAGEMENT LLC 18% 0% $1,360,366 1,020,300 0% Poplar Point Capital Management LLC 15 Oct 2025

As of 31 Dec 2025, 25 institutional investors reported holding 6,077,642 shares of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY). This represents 4.7% of the company’s total 128,016,032 outstanding shares.

Institutional Holders of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,077,642 $34,281,889 +$33,149,447 $5.64 25
2025 Q3 226,658 $289,923 +$135,649 $1.28 12
2025 Q2 218,521 $126,742 -$84,498 $0.58 11
2025 Q1 362,238 $211,908 +$113,243 $0.58 15
2024 Q4 167,029 $100,725 +$22,013 $0.60 14
2024 Q3 125,970 $87,462 +$79,537 $0.69 12
2024 Q2 11,501 $25,420 +$25,420 $2.24 7